Holen Sie sich die Stockscreener-App
91.04
1.51%
1.35
Handel nachbörslich:
91.04
Schlusskurs vom Vortag:
$89.69
Offen:
$89.43
24-Stunden-Volumen:
1.79M
Relative Volume:
0.82
Marktkapitalisierung:
$17.36B
Einnahmen:
$8.41B
Nettoeinkommen (Verlust:
$760.80M
KGV:
23.64
EPS:
3.8513
Netto-Cashflow:
$1.05B
1W Leistung:
-4.53%
1M Leistung:
-9.18%
6M Leistung:
+3.88%
1J Leistung:
-6.12%
1-Tages-Spanne:
$89.24
$91.84
1-Wochen-Bereich:
$89.02
$95.66
52-Wochen-Spanne:
$79.12
$106.88
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Firmenname
Zimmer Biomet Holdings Inc
Sektor
Branche
Telefon
(574) 267-6131
Adresse
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
91.04 | 17.36B | 8.41B | 760.80M | 1.05B | 3.8513 |
ABT
Abbott Laboratories
|
101.29 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
88.64 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
272.36 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.92 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.29 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-23 | Herabstufung | BTIG Research | Buy → Neutral |
| 2026-02-20 | Eingeleitet | William Blair | Mkt Perform |
| 2026-01-09 | Herabstufung | Goldman | Neutral → Sell |
| 2026-01-06 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2026-01-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-12-16 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-09-18 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-07-15 | Hochstufung | Roth Capital | Neutral → Buy |
| 2024-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-07-01 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-21 | Hochstufung | Argus | Hold → Buy |
| 2024-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Eingeleitet | ROTH MKM | Neutral |
| 2023-08-28 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-05-03 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Hochstufung | Jefferies | Underperform → Hold |
| 2023-03-29 | Eingeleitet | UBS | Sell |
| 2023-03-10 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Underweight |
| 2022-10-12 | Eingeleitet | Jefferies | Underperform |
| 2022-05-27 | Herabstufung | Needham | Buy → Hold |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2022-04-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-03-02 | Fortgesetzt | BofA Securities | Underperform |
| 2022-03-02 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-02-08 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Bestätigt | Citigroup | Buy |
| 2022-02-08 | Bestätigt | Deutsche Bank | Hold |
| 2022-02-08 | Bestätigt | JMP Securities | Mkt Outperform |
| 2022-02-08 | Bestätigt | JP Morgan | Neutral |
| 2022-02-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Bestätigt | Stifel | Buy |
| 2022-02-08 | Bestätigt | Truist | Buy |
| 2022-02-08 | Bestätigt | UBS | Neutral |
| 2022-02-08 | Bestätigt | Wells Fargo | Underweight |
| 2022-02-02 | Herabstufung | UBS | Buy → Neutral |
| 2022-01-19 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Herabstufung | Needham | Strong Buy → Buy |
| 2021-12-07 | Eingeleitet | Loop Capital | Buy |
| 2021-11-23 | Herabstufung | Argus | Buy → Hold |
| 2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-09 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Bestätigt | Needham | Strong Buy |
| 2020-10-20 | Eingeleitet | Northland Capital | Market Perform |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-08-05 | Bestätigt | Needham | Strong Buy |
| 2020-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Bestätigt | Needham | Strong Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2020-01-07 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Hochstufung | BTIG Research | Neutral → Buy |
| 2019-09-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Hochstufung | Argus | Hold → Buy |
| 2019-07-30 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Hochstufung | Needham | Buy → Strong Buy |
Alle ansehen
Zimmer Biomet Holdings Inc Aktie (ZBH) Neueste Nachrichten
Zimmer Biomet (ZBH): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Zimmer Biomet stock trades at USD 91.57, up 2.10 percent in New York trading - AD HOC NEWS
Zimmer Biomet Holdings (ZBH) Pushes Cost Reset Plans, Is It Still 17% Below Fair Value? - Yahoo Finance
Zimmer Biomet stock falls 1.31 percent despite higher 2026 guidance - AD HOC NEWS
Zimmer Biomet Holdings, Inc. (ZBH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Zimmer Biomet Holdings, Inc. $ZBH Holdings Lifted by State Street Corp - marketbeat.com
A Look at Zimmer Biomet Holdings Inc (ZBH) After 3.3% Decline -- GF Value $125.18 vs Price $90.88 - GuruFocus
Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know - Yahoo Finance
Why Zimmer Biomet (ZBH) Stock Is Down Today - Quiver Quantitative
Minimally Invasive Robotic Surgical System Market Global Report 2026: Benchmark Intuitive Surgical, Johnson & Johnson, Medtronic, Stryker and Zimmer Biomet Now - Yahoo Finance
Zimmer Biomet stock slips as shares close at USD 94.32 - AD HOC NEWS
Nykredit A S Takes $3.22 Million Position in Zimmer Biomet Holdings, Inc. $ZBH - marketbeat.com
Zimmer Biomet stock slips 1.1 percent ahead of the open - AD HOC NEWS
Zimmer Biomet stock holds near USD 94 as analysts see upside - AD HOC NEWS
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Given Average Recommendation of "Hold" by Brokerages - marketbeat.com
Zimmer Biomet stock heads into the open after a 1.2 percent gain - AD HOC NEWS
Zimmer Biomet Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Zimmer Biomet Holdings, Inc. (ZBH) Investor Outlook: Strong Potential Upside with 12.81% Amid Robust Product Portfolio - DirectorsTalk Interviews
The Best Healthcare Stocks to Buy - Morningstar
ETFs Investing in Zimmer Biomet Holdings, Inc. Stocks - TradingView
Zimmer Biomet Holdings, Inc. rStock (RZBH) Price Prediction for 2026 to 2031 - Bybit
Zimmer Biomet to Showcase Complete Shoulder Solution Designed to Support Surgeon Flexibility - Ortho Spine News
2,177,724 Shares in Zimmer Biomet Holdings, Inc. $ZBH Purchased by Bank of America Corp DE - MarketBeat
Zimmer Biomet Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Is Zimmer Biomet Stock Underperforming the Nasdaq? - Yahoo Finance
Zimmer Biomet Mid-Year Report: Hips Move but Knees Take the Scenic Route - Orthopedics This Week
Zimmer Biomet (ZBH) Insider Sale: Grp Pres-Global Business Kevin Thornal Sells 5,691 Shares, Now Holds 0 - GuruFocus
Zimmer Biomet (NYSE: ZBH) leader now reports no direct stock holdings - Stock Titan
Zimmer Biomet Holdings Inc (ZBH) Shares Surge 3.3% -- What GF Sc - GuruFocus
How Zimmer Biomet’s New Americas and Robotics Leadership Structure At Zimmer Biomet Holdings (ZBH) Has Changed Its Investment Story - Yahoo Finance
Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating A 15% Upside Potential - DirectorsTalk Interviews
Engineers Gate Manager LP Makes New $6.16 Million Investment in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
California State Teachers Retirement System Purchases 26,490,456 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
BMO Capital initiates coverage on Zimmer Biomet with $95 target - scanx.trade
Kevin R. Thornal plans $529K Zimmer Biomet (NYSE: ZBH) stock sale - Stock Titan
Zimmer Biomet stock slips after Winterthur job-cut plan and leadership changes - ad-hoc-news.de
Zimmer Biomet Holdings, Inc. $ZBH Shares Bought by Amundi - MarketBeat
Zimmer Biomet stock heads into the open after a 2.4% drop - ad-hoc-news.de
Zimmer Biomet stock slips as guidance and jobs cuts weigh - ad-hoc-news.de
Zimmer restructures Americas leadership team - Yahoo Finance
Zimmer Biomet SVP, Chief Legal & Corporate Affairs Officer Chad F. Phipps disposes of 3,000 common shares worth $295,050 - Bitget
Zimmer Biomet stock heads into the open after a 3.9 percent drop - ad-hoc-news.de
Zimmer Biomet Executive Chad F. Phipps Sells 3,000 Shares at $98.35 Each - Kalkine Media
Chad Phipps Sells 3,000 Shares of Zimmer Biomet (NYSE:ZBH) Stock - MarketBeat
Zimmer Biomet Holdings Insider Sold Shares Worth $295,050, According to a Recent SEC Filing - marketscreener.com
Zimmer Biomet (NYSE: ZBH) officer sells 3,000 shares for about $295K - Stock Titan
Sept. 3: Zimmer Biomet moving HQ, donating former one to area college - Fort Wayne Business Weekly
Truist Financial Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating - Moomoo
Zimmer Biomet stock falls after leadership moves and guidance reiteration - ad-hoc-news.de
Finanzdaten der Zimmer Biomet Holdings Inc-Aktie (ZBH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.08%
0.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):